Skip to main content
Clinical Trials/NCT05432180
NCT05432180CompletedNot Applicable

Human Milk Nutrients and Infants' Health Outcomes in South China

Huilian Zhu1 site in 1 country80 target enrollmentStarted: June 6, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
The growth of children

Study Overview

Brief Summary

The purpose of this study is to investigate the associations between human milk nutrients and infants' health outcomes in China.

Detailed Description

Human milk components are beneficial to the growth and development of infants, such as phospholipids, gangliosides, sialic acids, choline, oligosaccharide and so on. However, studies on the associations between human milk components and infants' outcomes are limited. Therefore, this study is designed to investigate the relationship between Chinese human milk components and the growth and development of infants.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
4 Years to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age 4-5 years
  • healthy children
  • breastfeeding between 0 to 400 days of age
  • human milk components in human milk being determined
  • sign informed consent

Exclusion Criteria

  • children with severe chronic diseases, such as tumor, severe digestive diseases, kidney diseases
  • gestational diabetes, hypertension and other metabolic diseases
  • children with mental system diseases
  • children with congenital and genetic diseases
  • children with infectious diseases, eg, upper respiratory tract infection or diarrhea
  • antibiotic or other drugs influencing intestinal flora being taken within 45 days
  • Withdraw withdraw informed consent serious violation of the scheme no longer meet the research criteria because of health factors or accidents

Outcomes

Primary Outcomes

The growth of children

Time Frame: 18 month

The physical growth and body composition of children will be checked by physical examination.

The cognitive development of children

Time Frame: 18 month

The brain developments of children will be obtained by the Griffith Developmental Assessment Scale.

Gut microbiota

Time Frame: 6 month

Gut microbiota of children will be examined by the analysis of 16S rDNA and metagenomic.

Secondary Outcomes

  • Dietary and lifestyle information(3 month)
  • Allergic assessment(18 month)
  • General demographic materials(14 month)
  • Behavior problems(18 month)
  • Sleep assessment(18 month)

Investigators

Sponsor
Huilian Zhu
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Huilian Zhu

Professor

Sun Yat-sen University

Study Sites (1)

Loading locations...

Similar Trials